We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1913:HKEXPrada S.p.A. Analysis

Data as of 2026-03-15 - not real-time

HK$39.08

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Prada shares are trading at HK$39.08, just above the 20‑day SMA (HK$41.86) and comfortably under the 200‑day SMA (HK$45.29), signaling a short‑term bearish bias. The MACD line sits below its signal line and the histogram is negative, while the 14‑day RSI at 38 suggests the stock is approaching oversold territory. Current price remains above the calculated support of HK$37.62 but well beneath the resistance level of HK$45.18, and the 30‑day volatility of over 33% combined with a low beta (≈0.4) points to heightened price swings despite limited market‑wide correlation. Volume trends are increasing, providing some liquidity cushion as the price tests these technical thresholds.
Fundamentally, Prada delivers strong profitability with an 80% gross margin and a 23.7% operating margin on revenues of HK$5.7 bn, while earnings per share have risen to HK$2.97 and the forward PE contracts to 11.8. The stock offers an attractive dividend yield of 3.85% backed by a 49% payout ratio and solid cash flow, and the DCF‑derived upside of roughly 43% (median analyst target HK$57.13) suggests the market is undervaluing the brand’s premium positioning and growth prospects.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Price marginally above technical support
  • Oversold RSI indicating potential rebound
  • Attractive dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Valuation gap with ~43% upside to analyst targets
  • Strong profit margins and cash generation
  • Consistent dividend policy

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Premium brand positioning in luxury segment
  • Sustainable earnings growth and cash flow
  • Resilient dividend supported by solid balance sheet

Key Metrics & Analysis

Financial Health

Revenue Growth3.30%
Profit Margin14.90%
P/E Ratio13.2
ROE18.82%
ROA8.46%
Debt/Equity103.40
P/B Ratio2.4
Op. Cash FlowHK$1.7B
Free Cash FlowHK$899.3M

Technical Analysis

TrendBearish
RSI37.8
SupportHK$37.62
ResistanceHK$45.18
MA 20HK$41.86
MA 50HK$41.93
MA 200HK$45.29
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueHK$4.11
Target PriceHK$56.02
Upside/Downside43.34%
GradeUndervalued
TypeBlend
Dividend Yield3.85%

Risk Assessment

Beta0.40
Volatility33.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.